Recruiting
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
NCT06830031
- Conditions
- DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China